DR. MARY LYNN MORAN, M.D.
Medical Practice at Woodside Rd, Redwood City, CA
License number
California G-076828
Category
Medical Practice
Type
Plastic Surgery Within the Head and Neck
Address
Address
2973 Woodside Rd, Redwood City, CA 94062
Phone
(650) 851-0565
(650) 851-0520 (Fax)
(650) 851-0520 (Fax)
Professional information
Mary Moran - Redwood City, CA
Work:
Redwood City Police Department - Redwood City, CA
911 Communication Dispatcher Aging and Adult Services of San Mateo County - San Mateo, CA
Public Service Specialist
911 Communication Dispatcher Aging and Adult Services of San Mateo County - San Mateo, CA
Public Service Specialist
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
2012010, Apr 26, 2012
Filed:
Dec 30, 2011
Appl. No.:
13/341732
Inventors:
Donald J. EATON - Los Altos CA, US
Mary Lynn Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary Lynn Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
International Classification:
A61M 31/00
US Classification:
604 60
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7713255, May 11, 2010
Filed:
Apr 7, 2009
Appl. No.:
12/419930
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00
US Classification:
604506, 604510, 604514
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
2005004, Feb 24, 2005
Filed:
Mar 12, 2004
Appl. No.:
10/800162
Inventors:
Donald Eaton - Woodside CA, US
Mary Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
Mary Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
International Classification:
A61M031/00
US Classification:
604500000, 604891100, 424422000
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e.g., an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7951130, May 31, 2011
Filed:
Sep 15, 2010
Appl. No.:
12/883059
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00, A61F 13/00
US Classification:
604506, 604510, 604514, 424434
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
8109918, Feb 7, 2012
Filed:
Jun 6, 2009
Appl. No.:
12/479794
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00
US Classification:
604514, 604506
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7951131, May 31, 2011
Filed:
Sep 15, 2010
Appl. No.:
12/883079
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00, A61F 13/00
US Classification:
604506, 604510, 604514, 424434
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7951135, May 31, 2011
Filed:
Sep 15, 2010
Appl. No.:
12/883090
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00, A61F 13/00
US Classification:
604514, 604506, 604510, 424434
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7951132, May 31, 2011
Filed:
Oct 24, 2008
Appl. No.:
12/258277
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary Lynn Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary Lynn Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect, ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00, A61F 13/00
US Classification:
604514, 604506, 604510, 424434
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.
Sinus Delivery Of Sustained Release Therapeutics
US Patent:
7951134, May 31, 2011
Filed:
Sep 15, 2010
Appl. No.:
12/883056
Inventors:
Donald J. Eaton - Los Altos CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Mary L. Moran - Woodside CA, US
Rodney A. Brenneman - San Juan Capistrano CA, US
Assignee:
Intersect ENT, Inc. - Palo Alto CA
International Classification:
A61M 31/00, A61F 13/00
US Classification:
604514, 604510, 604506, 424434
Abstract:
The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biodegradable implants include a sustained release therapeutic, e. g. , an antibiotic, a steroidal anti-inflammatory agent, or both. The biodegradable implants may take various forms, such as rods, pellets, beads, strips, or microparticles, and may be delivered into a sinus in various pharmaceutically acceptable carriers.